This session included the following trials and research:
- Efficacy Of Semaglutide In Patients With Obesity And HFpEF According To Frailty Status: A Pooled Analysis From The STEP-HFpEF Program
- Effects Of Semaglutide In Patients With Obesity-related Heart Failure With Preserved Ejection Fraction According To The Exercise Function At Baseline: Insights From The STEP-HFpEF Program
- Efficacy And Safety Of Finerenone In Patients With Heart Failure And Mildly Reduced Or Preserved Ejection Fraction And A Recent Worsening Heart Failure Event: The FINEARTS-HF Trial
- Efficacy And Safety Of Finerenone Across The Ejection Fraction Spectrum In Heart Failure With Mildly Reduced And Preserved Ejection Fraction: The FINEARTS-HF Trial
- Exploratory Biomarker Analyses From HELIOS-B, A Phase 3 Study of Vutrisiran In Patients with Transthyretin Amyloidosis with Cardiomyopathy
-
Effects of Vutrisiran on Echocardiographic Cardiac Structure and Function: The HELIOS-B Trial